Drug Adherence in Hypertension and Cardiovascular Protection
https://libcat.nshealth.ca/en/permalink/provcat43140
Michel Burnier, editor.
--Cham:
Springer
, c2018.
- Available Online
- View e-Book
- Location
- Online
This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complic…
- Available Online
- View e-Book
- Other Authors
- Burnier, Michel
- Other Authors
- European Society of Hypertension
- Responsibility
- Michel Burnier, editor
- Place of Publication
- Cham
- Publisher
- Springer
- Date of Publication
- c2018
- Physical Description
- 1 online resource (viii, 314 p.) : 43 illus., 30 illus. in color
- ISBN
- 9783319765938
- 9783319765921 (print ed.)
- 9783319765945 (print ed.)
- ISSN
- 2366-4606
- Subjects (MeSH)
- Cardiovascular Diseases - drug therapy
- Hypertension - drug therapy
- Medication Adherence
- Risk Factors
- Specialty
- Cardiology
- Pharmacy
- Abstract
- This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherence and shed light on how to identify patients at risk of poor adherence. Drug therapies in chronic diseases rely heavily on the patient's adherence, since drugs that are not taken are ineffective and leave the patient at high risk of developing clinical complications. Given the absence of new drugs for the treatment of hypertension, drug adherence is particularly important in these patients to improve blood pressure control. The book further investigates a new aspect, namely the importance of drug adherence in clinical trials and studies and draws attention to the limits of developing drugs without significant information on drug adherence. Several chapters are dedicated to the importance of adherence in specific forms of hypertension, such as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of several interventions aimed at improving drug adherence and put particular emphasis on the importance of an interdisciplinary approach involving nurses and pharmacists. The volume also includes a careful analysis of the health and economic impact of poor adherence. The book is aimed at physicians, pharmacists, students and all health professionals dealing not only with hypertension or dyslipidemia, but also with chronic asymptomatic diseases such as diabetes, HIV or chronic respiratory diseases.
- Contents
- 1. Taxonomy of Medication Adherence: Recent Developments -- Part I. Measuring Drug Adherence -- 2. Qualitative Assessments of Adherence -- 3. Electronic Monitoring of Medication Adherence: From Dose-Counting to Dose-Clocking -- 4. Measurements of Antihypertensive Medications in Blood and Urine -- 5. Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the Lombardy Database -- 6. Directly Observed Therapy in Hypertension (DOT-HTN) -- 7. Digital Medicines to Measure Drug Ingestion Adherence -- 8. Ethical Aspects of Measuring Adherence to Antihypertensive Treatment -- Part II. Risk Factors for Non-adherence -- 9. Determinants and Barriers to Adherence in Hypertension 10. Beliefs and Adherence in Hypertension and Cardiovascular Protection -- Part III. Adherence in Hypertension and CV Protection -- 11. Impact of Drug Adherence in Clinical Trials -- 12. The Impact of Antihypertensive Drugs on Adherence -- 13. Medication Persistence in Hypertension in General Practice -- 14. Drug Adherence in Resistant Hypertension -- 15. Drug Adherence with Cardiovascular Medicines: Statins and Aspirin -- 16. Which Interventions Are Useful? -- 17. Use of Fixed-Dose Combinations in Hypertension and Cardiovascular Disease Prevention -- 18. Nurse Led Interventions in Hypertension -- 19. Role of the Pharmacist in Supporting Adherence -- 20. Integrated Approaches to Support Medication Adherence: The Case of Hypertension - 21. Use of Apps to Improve Drug Adherence in Hypertensive Patients -- Part IV. Health Care Consequences of Non-adherence -- 22. Global Clinical Consequences of Poor Adherence.
- Format
- e-Book
- Location
- Online
